ICD-10 Coding for Acute Encephalopathy Documentation, and Billing Guidelines  

Last Updated on July 30, 2026

ICD-10 coding for acute encephalopathy does not begin with one default code. The correct code depends on how the provider defines the condition, whether the cause is metabolic, toxic, hepatic, hypertensive, or unspecified, and how clearly the diagnosis is supported across the medical record.

This distinction can affect severity reporting, MS-DRG assignment, quality data, reimbursement, and clinical validation risk. Using an unspecified code when the documentation supports a more precise diagnosis may underrepresent the patient’s condition. Assigning metabolic or toxic encephalopathy without clear provider documentation can also create compliance concerns and increase payer scrutiny.

Accurate reporting requires alignment between the provider’s final diagnosis, the supporting record, and applicable sequencing rules. Providers, CDI teams, coders, and billing professionals must therefore review the complete clinical record before finalizing the claim.

ICD-10-CM Codes for Acute Encephalopathy

There is no single ICD-10-CM code for every acute encephalopathy case. G93.40 may apply to unspecified encephalopathy, G93.41 to metabolic encephalopathy, and G92.8 to other toxic encephalopathy, depending on the provider’s final documentation.

Coders should locate the documented diagnosis in the Alphabetic Index and verify the selection in the Tabular List. This review may identify inclusion terms, exclusions, code-first instructions, or additional-code requirements. 

ICD-10-CM code	Description	General Application
G93.40	Encephalopathy, unspecified	The provider confirms encephalopathy but does not identify the type
G93.41	Metabolic encephalopathy	A metabolic or systemic disturbance causes the encephalopathy
G92.8	Other toxic encephalopathy	Documentation supports a specified toxic or toxic-metabolic form
G92.9	Unspecified toxic encephalopathy	The provider documents toxic encephalopathy without further specificity
G93.49	Other encephalopathy	Another specified form is documented and no more specific code applies
K76.82	Hepatic encephalopathy	The condition is linked to hepatic dysfunction
I67.4	Hypertensive encephalopathy	The provider links the cerebral dysfunction to severe hypertension

The table provides a quick reference. Other condition-specific codes may apply, including G93.49 for other specified encephalopathy, K76.82 for hepatic encephalopathy, and I67.4 for hypertensive encephalopathy. Coders should verify the exact documented diagnosis and confirm that no more specific code applies.  

Coding Acute Metabolic Encephalopathy With G93.41

Code G93.41 applies when the provider documents metabolic encephalopathy caused by an internal metabolic or systemic disturbance.

A clear diagnostic statement should identify both the encephalopathy and its underlying cause:

“Acute metabolic encephalopathy due to severe hyponatremia.”

This wording establishes a direct relationship between the two conditions. By comparison, “encephalopathy with hyponatremia” lists both diagnoses but does not confirm that the electrolyte disturbance caused the encephalopathy.

Coders should not assign G93.41 from laboratory values or clinical findings alone. The provider must establish metabolic encephalopathy, while the medical record should support the acute cognitive change and the care provided.

Coding Acute Toxic Encephalopathy With G92.8

Code G92.8, Other toxic encephalopathy, may apply when the provider documents a specified toxic or toxic-metabolic form. Potential causes include prescription medications, illicit drugs, alcohol, chemicals, or environmental toxins.

Documentation should identify the responsible agent whenever possible:

“Acute toxic encephalopathy secondary to lithium toxicity.”

“Acute toxic encephalopathy caused by an adverse effect of a prescribed sedative.”

Medication-related cases also require documentation of whether the patient took the medication correctly or experienced poisoning through an incorrect drug, dose, or method of use. These circumstances affect sequencing and should be reviewed before the claim is finalized.

When the provider documents toxic encephalopathy without further specificity, G92.9 may apply.

When to Use G93.40 for Encephalopathy, Unspecified

Code G93.40 may apply when the provider confirms encephalopathy but does not identify a metabolic, toxic, or other specific type. Documentation of “acute encephalopathy” may still result in G93.40 because the word “acute” identifies timing rather than etiology.

An unspecified code is not automatically inaccurate. It may correctly reflect cases in which the clinical team cannot determine the mechanism. When the documentation does not support a clear subtype, coders should seek provider clarification rather than infer a more specific diagnosis. 

Coders should not independently change unspecified encephalopathy to a more specific form. Any clarification must come from the responsible provider and remain supported by the record.

Once the appropriate code family is identified, the documentation must support the reported type, underlying cause, and acuity. 

How to Select the Correct Acute Encephalopathy Code

The ICD-10-CM code should reflect the provider’s final diagnosis and the level of specificity supported by the medical record. Coders should not select a specific encephalopathy code based only on laboratory findings, symptoms, or suspected etiology when the provider has not clearly documented that diagnosis.

Before assigning the code, review:

• Whether encephalopathy is documented as a confirmed diagnosis
• The specific type of encephalopathy identified
• The underlying condition or external cause
• Whether drug or toxic exposure is involved
• Whether the condition is acute, chronic, or unspecified
• Whether the record documents only symptoms such as confusion or altered mental status
• Applicable instructional notes, sequencing guidance, and additional-code requirements

A Practical Coding Decision Path

1. Is encephalopathy documented as a confirmed diagnosis?
If not, report the documented symptoms or query the provider when clinical indicators suggest encephalopathy but the diagnosis remains unclear.

2. Is a specific type documented?
Choose the code that reflects the documented condition, such as metabolic, toxic, or other specified encephalopathy. Avoid defaulting to unspecified encephalopathy when greater specificity is available.

3. Is the cause clearly linked to encephalopathy?
Review whether the provider connects the cerebral dysfunction to a metabolic disturbance, medication, toxic exposure, organ failure, infection, or another condition.

4. Are additional codes or sequencing instructions required?
Certain encephalopathy categories may require reporting the underlying condition, drug, toxic agent, or adverse effect according to ICD-10-CM instructions.

5. Does the documentation support clinical validation?
Confirm that the record reflects an acute change from baseline, relevant clinical findings, evaluation, treatment, and provider assessment.

Note: The code should follow the documented diagnosis, not an assumed relationship between symptoms, laboratory abnormalities, and encephalopathy.

Documentation Requirements for Accurate Encephalopathy Coding

The record must establish more than confusion, lethargy, or reduced responsiveness. It should identify the encephalopathy type, explain the cause when known, and distinguish the acute condition from the patient’s usual cognitive status.

Essential Documentation Elements

A well-supported diagnosis should include:

• Specific encephalopathy type
• Underlying cause and documented relationship
• Cognitive baseline and acute change
• Relevant clinical findings
• Treatment, monitoring, and response
• Diagnosis status at discharge

Baseline documentation is especially important for patients with dementia, previous neurological injury, or chronic cognitive impairment. The statement “confused patient with dementia” does not independently establish acute encephalopathy.

Weak vs Strong Documentation

Incomplete documentation

“Patient confused and lethargic. Possible encephalopathy.”

More specific documentation

Acute metabolic encephalopathy due to severe hyponatremia, with new disorientation from an alert and oriented baseline. Mental status improved after sodium correction.

When a CDI Query May Be Appropriate

A compliant query may be appropriate when:

• Different encephalopathy types appear in the record.
• The attending physician and consultant use conflicting terminology.
• Delirium, altered mental status, and encephalopathy appear inconsistently.
• The cause lacks a clear relationship to the diagnosis.
• The record does not distinguish the condition from baseline impairment.
• The discharge summary omits or contradicts earlier documentation.

Coders should seek provider clarification when incomplete or conflicting documentation prevents accurate code assignment. Supported documentation must then be translated into correct sequencing based on the care setting, reason for admission, and applicable code instructions. 

Sequencing and Billing Implications of Acute Encephalopathy

Selecting a higher-impact code without adequate support can lead to denials, repayment risk, and appeal works. Coders must also consider the reason for admission, care setting, underlying condition, and any code-specific sequencing instructions. 

Principal Diagnosis Selection

Acute encephalopathy does not automatically qualify as the principal diagnosis. For inpatient claims, coders must identify the condition established after study as chiefly responsible for the admission.

Encephalopathy may serve as the principal diagnosis when it primarily drives the hospitalization, evaluation, and treatment. In other cases, sepsis, respiratory failure, poisoning, organ dysfunction, or another underlying condition may sequence first.

Coders should review:

• The reason for admission
• The condition established after study as chiefly responsible for admission 
• Code-first and additional-code instructions
• Final discharge diagnoses
• Present-on-admission status

The complete circumstances of the encounter, not the reimbursement value of an individual code must guide sequencing.

Inpatient vs Outpatient Coding

For inpatient discharges:

• Probable, suspected, likely, or possible diagnoses may be reported under inpatient uncertain-diagnosis rules.
• Present-on-admission status should be reviewed.
• Secondary diagnoses must meet reporting requirements.

For physician offices, emergency departments, and observation services:

• Uncertain diagnoses cannot be reported as confirmed.
• Coders should report the highest level of certainty available.
• Symptoms may remain reportable when no definitive diagnosis is established.

Medication Adverse Effect vs Poisoning

Adverse effect	Poisoning
Medication was taken correctly	Wrong drug, dose, or method of use
The manifestation generally sequences first	The poisoning code generally sequences first
Add the drug code with the adverse-effect character	Add the resulting manifestations after the poisoning code
Example: reaction to a prescribed dose	Example: accidental overdose

Coders should review the provider’s statement and the Table of Drugs and Chemicals before assigning and sequencing the codes. The medication name alone does not determine whether the case represents an adverse effect or poisoning.

Reimbursement and Denial Considerations

Encephalopathy coding may influence:

• MS-DRG and severity reporting
• Medical necessity and claim accuracy
• Clinical validation and audit exposure
• Quality and reimbursement reporting

The final payment effect depends on the complete claim, including the principal diagnosis, secondary conditions, procedures, discharge status, and applicable grouper logic. 

Selecting a higher-impact code without adequate support can lead to denials, repayment risk, and appeal work.These requirements also reveal where acute encephalopathy claims most often become vulnerable.

Common Acute Encephalopathy Coding Errors

Even when the correct code appears in the record, incomplete documentation or incorrect sequencing can make the claim vulnerable to payer review.

Common Error	Why It Creates Risk
Defaulting to G93.40	May overlook clinically supported specificity
Inferring G93.41 from laboratory findings	The provider must establish metabolic encephalopathy
Missing the patient’s cognitive baseline	Weakens support for an acute change
Omitting the underlying cause	Creates an incomplete clinical picture
Misclassifying adverse effects and poisoning	Can result in incorrect code sequencing
Ignoring conflicting terminology	May lead to inaccurate code assignment
Sequencing based on financial impact	Does not follow official coding guidance

A second-level review may be appropriate when encephalopathy affects severity reporting, the provider documentation conflicts, or the claim carries a high clinical validation risk. 

Accurate Coding Begins With Clear Documentation

Accurate ICD-10 coding for acute encephalopathy requires alignment between the provider’s final diagnosis, supporting clinical record, and applicable sequencing rules. When providers, CDI teams, and coders follow a consistent review process, healthcare organizations can improve claim accuracy, reduce unsupported coding, and strengthen their defense against clinical validation denials.

FAQs

1. What is the difference between G93.40 and G93.41?

G93.40 represents unspecified encephalopathy, while G93.41 represents metabolic encephalopathy. G93.41 requires provider documentation that identifies the condition as metabolic rather than merely describing an acute change in mental status.

2. Can acute encephalopathy be the principal diagnosis?

Yes, when it is established after study as the condition chiefly responsible for the inpatient admission. The complete circumstances of the encounter and applicable sequencing instructions determine principal diagnosis selection.

3. Can altered mental status be coded with confirmed encephalopathy?

A separate symptom code is generally unnecessary when confirmed encephalopathy explains the altered mental status. Coders should review the final documentation and applicable reporting instructions.

4. Can dementia and acute encephalopathy be coded together?

Yes. The provider should establish both conditions and document how the acute encephalopathy differs from the patient’s chronic cognitive baseline.

5. Does G93.41 always affect the MS-DRG?

No. The impact depends on the complete claim, including the principal diagnosis, secondary conditions, procedures, exclusion logic, and applicable grouper.

6. Should every G93.40 case receive a provider query?

No. G93.40 may accurately represent a case in which the clinical team cannot determine the encephalopathy type. A query is appropriate only when clarification is clinically reasonable.

7. What should an encephalopathy denial appeal include?

The appeal should include the provider’s diagnostic statement, baseline mental status, acute findings, underlying cause, treatment, response, discharge documentation, and relevant coding or payer guidance.

8. How often should encephalopathy claims be audited?

Audit frequency should reflect claim volume, coding patterns, payer activity, and denial trends. Organizations experiencing frequent clinical validation denials may benefit from targeted reviews.